CareDx to Report Third Quarter 2025 Financial Results on November 4, 2025

Audio By Carbonatix

BRISBANE, Calif.--(BUSINESS WIRE)--Oct 21, 2025--

CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers – today announced it will report financial results for the third quarter 2025 after market close on Tuesday, November 4, 2025. The Company will host a webcast and conference call that day at 1:30 p.m. PT / 4:30 p.m. ET.

A live and archived webcast of the conference call can be accessed on the Events & Presentations section of CareDx’s Investor Relations website at investors.caredx.com. To participate in the live conference call via telephone, register here. Upon registering, a dial-in number and unique PIN will be provided.

About CareDx – The Transplant Company

CareDx, Inc., headquartered in Brisbane, California, is a leading precision medicine solutions company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. CareDx offers testing services, products, and digital healthcare solutions along the pre- and post-transplant patient journey and is the leading provider of genomics-based information for transplant patients. For more information, please visit: www.CareDx.com.

Source: CareDx, Inc.

View source version on businesswire.com:https://www.businesswire.com/news/home/20251020102372/en/

CONTACT: Investor Contact

[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH MEDICAL DEVICES HOSPITALS SURGERY HEALTH TECHNOLOGY CLINICAL TRIALS BIOTECHNOLOGY

SOURCE: CareDx, Inc.

Copyright Business Wire 2025.

PUB: 10/21/2025 08:00 AM/DISC: 10/21/2025 08:00 AM

http://www.businesswire.com/news/home/20251020102372/en